Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1
2(66.7%)
N/A
1(33.3%)
3Total
Early Phase 1(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01859442Early Phase 1Completed

The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness

Role: lead

NCT02106286Early Phase 1Completed

Effects of Beta-blockade on Cardiopulmonary Exercise Testing

Role: lead

NCT01325909Not ApplicableCompleted

Exercise Training in Colorectal Cancer Patients

Role: lead

NCT01334593Completed

Assessment of Fitness After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients

Role: lead

All 4 trials loaded